Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000169
Filing Date
2024-12-02
Accepted
2024-12-02 06:00:40
Documents
8
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 6-K form6k_120224.htm 6-K 11719
2 EX-99.1 fy2024_ibr.htm EX-99.1 18039
3 GRAPHIC fy2024_ibr001.jpg GRAPHIC 216327
4 GRAPHIC fy2024_ibr002.jpg GRAPHIC 261809
5 GRAPHIC fy2024_ibr003.jpg GRAPHIC 218647
6 GRAPHIC fy2024_ibr004.jpg GRAPHIC 128888
7 GRAPHIC fy2024_ibr005.jpg GRAPHIC 213273
8 GRAPHIC fy2024_ibr006.jpg GRAPHIC 122846
  Complete submission text file 0001395064-24-000169.txt   1631409
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 241517295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)